View in EDS HTML Full Text PDF Full Text

STING‐ATF3/type I interferon crosstalk: A potential target to improve anti‐tumour immunity in chemotherapy‐treated urothelial carcinoma.

Saved in:
Bibliographic Details
Title: STING‐ATF3/type I interferon crosstalk: A potential target to improve anti‐tumour immunity in chemotherapy‐treated urothelial carcinoma.
Authors: Fauvre, Alexandra1 (AUTHOR), Machu, Margot1 (AUTHOR), Merienne, Audrey2 (AUTHOR), Vie, Nadia1 (AUTHOR), Bessede, Thomas1 (AUTHOR), Robin, Mathilde1 (AUTHOR), Garambois, Veronique1 (AUTHOR), Taffoni, Clara3 (AUTHOR), Laguette, Nadine3 (AUTHOR), Gervois‐Segain, Nadine2 (AUTHOR), Jarry, Anne2 (AUTHOR), Labarriere, Nathalie2 (AUTHOR), Allory, Yves4 (AUTHOR), Larbouret, Christel1 (AUTHOR), Gros, Laurent1 (AUTHOR), Tosi, Diego1 (AUTHOR), Solit, David B.5 (AUTHOR), Pourquier, Philippe1 (AUTHOR), Houédé, Nadine1 (AUTHOR), Gongora, Celine1 (AUTHOR) celine.gongora@inserm.fr
Source: Clinical & Translational Medicine. Sep2024, Vol. 14 Issue 9, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20011326
DOI:10.1002/ctm2.70011